Updated: March 26, 2026
What Is Mirabegron XR? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Overview
Mirabegron XR (Myrbetriq) is a beta-3 agonist for overactive bladder. Learn what it treats, how to take it, typical dosing, and everything you need to know in 2026.
Is Mirabegron XR in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Mirabegron XR near you.
Mirabegron XR is a prescription medication used to treat overactive bladder — one of the most common bladder conditions in the United States. Unlike most OAB drugs that have been around for decades, Mirabegron XR represents a newer class of treatment with a different mechanism and a cleaner side effect profile. Here is everything patients need to know about this medication in 2026.
What Is Mirabegron XR?
Mirabegron XR is the generic name for the extended-release form of mirabegron, an oral medication sold under the brand name Myrbetriq by Astellas Pharma. It belongs to a class of drugs called beta-3 adrenergic agonists — a class that was first introduced to U.S. patients with mirabegron's FDA approval in June 2012.
The "XR" or "ER" designation stands for extended-release, meaning the medication is slowly released from the tablet throughout the day. This allows for once-daily dosing. Mirabegron XR tablets should be swallowed whole — do not crush, chew, or break them, as this will disrupt the extended-release mechanism and release the full dose at once.
Check live stock now.
What Conditions Does Mirabegron XR Treat?
Mirabegron XR is FDA-approved to treat:
Overactive bladder (OAB) in adults: Including symptoms of urge urinary incontinence (leaking urine due to sudden urge), urgency (sudden strong urge to urinate), and urinary frequency (urinating 8+ times per 24 hours). It can be used alone or in combination with solifenacin (Vesicare).
Neurogenic detrusor overactivity (NDO) in pediatric patients: For children aged 3 years and older weighing at least 35 kg. Causes of NDO in children include spina bifida, spinal cord injury, and multiple sclerosis. Myrbetriq Granules (oral suspension) is available for younger children.
What Is Overactive Bladder (OAB)?
Overactive bladder is a condition in which the bladder muscle (detrusor) contracts involuntarily, creating a sudden, strong urge to urinate. OAB affects roughly 33 million Americans and is more common in older adults. Symptoms include:
Urgency: A sudden, strong urge to urinate that is difficult to defer
Frequency: Urinating 8 or more times in 24 hours
Nocturia: Waking up 2 or more times at night to urinate
Urge incontinence: Leaking urine before reaching the bathroom
How Is Mirabegron XR Dosed?
For adults with OAB:
Starting dose: 25 mg once daily (with or without food)
Dose increase: After 4-8 weeks, your doctor may increase to 50 mg once daily if needed for better symptom control
Maximum dose: 50 mg once daily for most patients
Severe kidney disease (eGFR 15-29): Maximum 25 mg/day; not recommended for dialysis patients
Moderate liver disease (Child-Pugh B): Maximum 25 mg/day; not recommended for severe liver disease
How to Take Mirabegron XR Correctly
Take once daily at approximately the same time each day
Swallow the tablet whole with water — do not crush, chew, or break it
Can be taken with or without food (adults)
If you miss a dose and less than 12 hours have passed, take it as soon as you remember
If more than 12 hours have passed since the missed dose, skip it and take your next regular dose
Store at room temperature (68-77°F); keep away from excess heat and moisture
When Does Mirabegron XR Start Working?
Mirabegron XR takes time to reach its full effect. Most patients notice some improvement within the first few weeks, but the full benefit may take 8 weeks or longer. Don't give up if you don't see dramatic results immediately — continue taking it as prescribed and follow up with your doctor.
Found
Rate
on average
Who Should NOT Take Mirabegron XR?
Patients with known allergy to mirabegron or any tablet ingredients
Patients with severe uncontrolled hypertension (SBP ≥180 mmHg or DBP ≥110 mmHg)
Patients with end-stage renal disease or severe liver impairment
For a full review of what to watch for once you start treatment, see our guide on Mirabegron XR side effects.
Frequently Asked Questions
Mirabegron XR and mirabegron ER both refer to the extended-release formulation of mirabegron — they are the same thing. The brand-name version is called Myrbetriq. All commercially available mirabegron tablets in the U.S. are extended-release. There is no immediate-release version of mirabegron available in the U.S.
Some patients notice improvement in OAB symptoms within the first few weeks of taking Mirabegron XR, but the full therapeutic effect may take up to 8 weeks. Clinical trials showed statistically significant reductions in urinary frequency and incontinence episodes within 12 weeks. Continue taking the medication as prescribed even if improvement is gradual.
There is no specific interaction between Mirabegron XR and alcohol documented in the prescribing information. However, alcohol is a bladder irritant and can worsen overactive bladder symptoms. Limiting alcohol intake is generally recommended for people with OAB regardless of their medication.
Yes. Myrbetriq is the brand name for mirabegron extended-release tablets, made by Astellas Pharma. Mirabegron XR (or mirabegron ER) refers to the same drug in its generic form, first approved by the FDA in September 2022 when Lupin Pharmaceuticals received clearance. Both contain the same active ingredient at the same doses (25 mg or 50 mg).
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Mirabegron XR also looked for:
More about Mirabegron XR
38,912 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





